0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Soliris Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-27P12006
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Soliris Drug Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Soliris Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-27P12006
Report
September 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Soliris Drug - Market Size

The global market for Soliris Drug was estimated to be worth US$ 3762 million in 2023 and is forecast to a readjusted size of US$ 1746.8 million by 2030 with a CAGR of -8.7% during the forecast period 2024-2030

Soliris Drug - Market

Soliris Drug - Market

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Soliris Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Soliris Drug by region & country, by Type, and by Application.
The Soliris Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris Drug.
Market Segmentation

Scope of Soliris Drug - Market Report

Report Metric Details
Report Name Soliris Drug - Market
Forecasted market size in 2030 US$ 1746.8 million
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • PNH
  • aHUS
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Soliris Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Soliris Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Soliris Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Soliris Drug - Market size in 2030?

Ans: The Soliris Drug - Market size in 2030 will be US$ 1746.8 million.

Who are the main players in the Soliris Drug - Market report?

Ans: The main players in the Soliris Drug - Market are AstraZeneca

What are the Application segmentation covered in the Soliris Drug - Market report?

Ans: The Applications covered in the Soliris Drug - Market report are PNH, aHUS, Other

What are the Type segmentation covered in the Soliris Drug - Market report?

Ans: The Types covered in the Soliris Drug - Market report are Plasma Exchange, Plasma Infusion

Recommended Reports

API Drug Markets

Disease Drug Markets

Therapeutics & Services

1 Market Overview
1.1 Soliris Drug Product Introduction
1.2 Global Soliris Drug Market Size Forecast
1.2.1 Global Soliris Drug Sales Value (2019-2030)
1.2.2 Global Soliris Drug Sales Volume (2019-2030)
1.2.3 Global Soliris Drug Sales Price (2019-2030)
1.3 Soliris Drug Market Trends & Drivers
1.3.1 Soliris Drug Industry Trends
1.3.2 Soliris Drug Market Drivers & Opportunity
1.3.3 Soliris Drug Market Challenges
1.3.4 Soliris Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Soliris Drug Players Revenue Ranking (2023)
2.2 Global Soliris Drug Revenue by Company (2019-2024)
2.3 Global Soliris Drug Players Sales Volume Ranking (2023)
2.4 Global Soliris Drug Sales Volume by Company Players (2019-2024)
2.5 Global Soliris Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Soliris Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Soliris Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Soliris Drug
2.9 Soliris Drug Market Competitive Analysis
2.9.1 Soliris Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Soliris Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Plasma Exchange
3.1.2 Plasma Infusion
3.2 Global Soliris Drug Sales Value by Type
3.2.1 Global Soliris Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Soliris Drug Sales Value, by Type (2019-2030)
3.2.3 Global Soliris Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Soliris Drug Sales Volume by Type
3.3.1 Global Soliris Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Soliris Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Soliris Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Soliris Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 PNH
4.1.2 aHUS
4.1.3 Other
4.2 Global Soliris Drug Sales Value by Application
4.2.1 Global Soliris Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Soliris Drug Sales Value, by Application (2019-2030)
4.2.3 Global Soliris Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Soliris Drug Sales Volume by Application
4.3.1 Global Soliris Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Soliris Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Soliris Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Soliris Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Soliris Drug Sales Value by Region
5.1.1 Global Soliris Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Soliris Drug Sales Value by Region (2019-2024)
5.1.3 Global Soliris Drug Sales Value by Region (2025-2030)
5.1.4 Global Soliris Drug Sales Value by Region (%), (2019-2030)
5.2 Global Soliris Drug Sales Volume by Region
5.2.1 Global Soliris Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Soliris Drug Sales Volume by Region (2019-2024)
5.2.3 Global Soliris Drug Sales Volume by Region (2025-2030)
5.2.4 Global Soliris Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Soliris Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Soliris Drug Sales Value, 2019-2030
5.4.2 North America Soliris Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Soliris Drug Sales Value, 2019-2030
5.5.2 Europe Soliris Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Soliris Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Soliris Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Soliris Drug Sales Value, 2019-2030
5.7.2 South America Soliris Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Soliris Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Soliris Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Soliris Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Soliris Drug Sales Value
6.2.1 Key Countries/Regions Soliris Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Soliris Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Soliris Drug Sales Value, 2019-2030
6.3.2 United States Soliris Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Soliris Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Soliris Drug Sales Value, 2019-2030
6.4.2 Europe Soliris Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Soliris Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Soliris Drug Sales Value, 2019-2030
6.5.2 China Soliris Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Soliris Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Soliris Drug Sales Value, 2019-2030
6.6.2 Japan Soliris Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Soliris Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Soliris Drug Sales Value, 2019-2030
6.7.2 South Korea Soliris Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Soliris Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Soliris Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Soliris Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Soliris Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Soliris Drug Sales Value, 2019-2030
6.9.2 India Soliris Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Soliris Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Information
7.1.2 AstraZeneca Introduction and Business Overview
7.1.3 AstraZeneca Soliris Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AstraZeneca Soliris Drug Product Offerings
7.1.5 AstraZeneca Recent Development
8 Industry Chain Analysis
8.1 Soliris Drug Industrial Chain
8.2 Soliris Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Soliris Drug Sales Model
8.5.2 Sales Channel
8.5.3 Soliris Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Soliris Drug Market Trends
    Table 2. Soliris Drug Market Drivers & Opportunity
    Table 3. Soliris Drug Market Challenges
    Table 4. Soliris Drug Market Restraints
    Table 5. Global Soliris Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Soliris Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Soliris Drug Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Soliris Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Soliris Drug Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Soliris Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Soliris Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Soliris Drug
    Table 13. Global Soliris Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Soliris Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Soliris Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Soliris Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Soliris Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Soliris Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Soliris Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Soliris Drug Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Soliris Drug Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Soliris Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Soliris Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Soliris Drug Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Soliris Drug Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Soliris Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Soliris Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Soliris Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Soliris Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Soliris Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Soliris Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Soliris Drug Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Soliris Drug Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Soliris Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Soliris Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Soliris Drug Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Soliris Drug Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Soliris Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Soliris Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Soliris Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Soliris Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Soliris Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Soliris Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Soliris Drug Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Soliris Drug Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Soliris Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Soliris Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Soliris Drug Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Soliris Drug Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Soliris Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Soliris Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Soliris Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Soliris Drug Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Soliris Drug Sales Volume, (2025-2030) & (K Units)
    Table 57. AstraZeneca Company Information
    Table 58. AstraZeneca Introduction and Business Overview
    Table 59. AstraZeneca Soliris Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. AstraZeneca Soliris Drug Product Offerings
    Table 61. AstraZeneca Recent Development
    Table 62. Key Raw Materials Lists
    Table 63. Raw Materials Key Suppliers Lists
    Table 64. Soliris Drug Downstream Customers
    Table 65. Soliris Drug Distributors List
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Soliris Drug Product Picture
    Figure 2. Global Soliris Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Soliris Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Soliris Drug Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Soliris Drug Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Soliris Drug Report Years Considered
    Figure 7. Global Soliris Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Soliris Drug Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Soliris Drug Revenue in 2023
    Figure 10. Soliris Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Plasma Exchange Picture
    Figure 12. Plasma Infusion Picture
    Figure 13. Global Soliris Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Soliris Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Soliris Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Soliris Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Soliris Drug Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of PNH
    Figure 19. Product Picture of aHUS
    Figure 20. Product Picture of Other
    Figure 21. Global Soliris Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Soliris Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Soliris Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Soliris Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Soliris Drug Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Soliris Drug Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Soliris Drug Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Soliris Drug Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Soliris Drug Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Soliris Drug Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Soliris Drug Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Soliris Drug Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Soliris Drug Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Soliris Drug Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Soliris Drug Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Soliris Drug Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Soliris Drug Sales Volume (%), (2019-2030)
    Figure 38. United States Soliris Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Soliris Drug Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Soliris Drug Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Soliris Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Soliris Drug Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Soliris Drug Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Soliris Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Soliris Drug Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Soliris Drug Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Soliris Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Soliris Drug Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Soliris Drug Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Soliris Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Soliris Drug Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Soliris Drug Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Soliris Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Soliris Drug Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Soliris Drug Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Soliris Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Soliris Drug Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Soliris Drug Sales Value by Application (%), 2023 VS 2030
    Figure 59. Soliris Drug Industrial Chain
    Figure 60. Soliris Drug Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona